NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife announced a quarterly dividend on Friday, July 6th. Investors of record on Monday, August 6th will be given a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a yield of 3.78%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its Board of Directors has approved a stock repurchase program on Tuesday, May 22nd 2018, which permits the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy up to 3.1% of its shares through open market purchases. Shares buyback programs are often an indication that the company's board of directors believes its stock is undervalued.

Metlife Inc (NYSE:MET) posted its quarterly earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.19. The financial services provider earned $15.15 billion during the quarter, compared to analyst estimates of $15.52 billion. Metlife had a net margin of 6.48% and a return on equity of 8.70%. The company's revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter last year, the business earned $1.20 earnings per share. View Metlife's Earnings History.

17 brokers have issued 1-year price targets for Metlife's stock. Their predictions range from $47.00 to $78.00. On average, they anticipate Metlife's stock price to reach $56.60 in the next twelve months. This suggests a possible upside of 27.4% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decrease in short interest in June. As of June 29th, there was short interest totalling 12,020,672 shares, a decrease of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily volume of 7,086,353 shares, the short-interest ratio is presently 1.7 days. Currently, 1.4% of the company's shares are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

News headlines about MET stock have trended positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Metlife earned a media sentiment score of 0.28 on Accern's scale. They also assigned news coverage about the financial services provider an impact score of 45.15 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Metlife's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Lodestar Investment Counsel LLC IL (0.04%), Gofen & Glossberg LLC IL (0.03%) and Fjarde AP Fonden Fourth Swedish National Pension Fund (0.02%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Gateway Investment Advisers LLC, Cullinan Associates Inc., Franklin Street Advisors Inc. NC, Fjarde AP Fonden Fourth Swedish National Pension Fund and CENTRAL TRUST Co. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc., State of Alaska Department of Revenue and IFM Investors Pty Ltd. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.44.

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.